<DOC>
	<DOCNO>NCT00320827</DOCNO>
	<brief_summary>This dose escalation study CS-1008 ( humanize anti-DR5 antibody ) determine recommend Phase 2 dose maximum tolerate dose . Drug administer six week possibly 12 week depend response .</brief_summary>
	<brief_title>Study CS-1008 Patients With Advanced Solid Malignancies Lymphomas ( Without Leukemic Component )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Histologically cytologically diagnose metastatic solid tumor lymphomas ( leukemic component ) refractory , curable , eligible standard treatment ( ) . Eighteen year age old Eastern Cooperative Oncology Group ( ECOG ) performance status equal le 2 Resolution toxic effect ( except alopecia ) prior therapy National Cancer Institute Common Terminology Criteria Adverse Events ( NCI CTCAE ) v3.0 grade equal le 1 Men woman childbearing potential must willing consent use effective contraception treatment least 3 month thereafter . All female patient childbearing potential must negative pregnancy test ( serum urine ) within 3 day prior treatment Patients must fully inform illness investigational nature study protocol Anticipation need major surgical procedure radiation therapy study Treatment chemotherapy , hormonal therapy , radiotherapy , major surgery , investigational agent within 4 week ( 6 week nitrosoureas , mitomycin C , immunotherapy , biological therapy , major surgery ) study enrollment Cumulative radiation therapy great 25 % total bone marrow Any follow within 6 month prior study enrollment : myocardial infarction , severe/unstable angina pectoris , coronary/peripheral artery bypass graft , New York Heart Association ( NYHA ) class III IV congestive heart failure , cerebrovascular accident transient ischemic attack , pulmonary embolism , deep vein thrombosis , clinically significant thromboembolytic event ; clinically significant pulmonary disease ( e.g. , severe chronic obstructive pulmonary disease [ COPD ] asthma ) Patients clinically active brain metastasis ( i.e. , treat still require therapy steroid radiotherapy [ RT ] ; progression 4 week completion RT ) uncontrolled seizure disorder , spinal cord compression , carcinomatous meningitis Clinically significant active infection require antibiotic therapy , HIVpositive patient receive antiretroviral therapy . Chronic diarrhea , inflammatory bowel disease , partial bowel obstruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Apoptosis</keyword>
	<keyword>Death receptor 5</keyword>
	<keyword>Cancer</keyword>
	<keyword>Advanced solid malignancy lymphomas ( without leukemic component )</keyword>
</DOC>